HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dominik Strzelecki Selected Research

Sarcosine (Methylglycine)

1/2021Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double-blind randomized controlled PULSAR study).
10/2018Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study).
1/2018Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).
8/2016BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).
7/2016MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).
12/2015No changes of cardiometabolic and body composition parameters after 6-month add-on treatment with sarcosine in patients with schizophrenia.
10/2015Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
10/2015Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.
10/2015Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
1/2015Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dominik Strzelecki Research Topics

Disease

26Schizophrenia (Dementia Praecox)
12/2021 - 05/2010
5Bipolar Disorder (Manic Depressive Psychosis)
12/2021 - 12/2013
4Depressive Disorder (Melancholia)
12/2021 - 06/2008
4Chronic Hepatitis C
11/2008 - 06/2008
3Mania (Manias)
07/2015 - 01/2014
2Inflammation (Inflammations)
02/2022 - 11/2021
2Psychotic Disorders (Schizoaffective Disorder)
01/2019 - 01/2019
2Neurobehavioral Manifestations
01/2015 - 01/2014
2Cognitive Dysfunction
05/2010 - 11/2008
1Autoimmune Hypothyroidism
03/2022
1Necrosis
02/2022
1Conduct Disorder (Conduct Disorders)
12/2021
1Hypoxia (Hypoxemia)
11/2021
1Weight Gain
01/2021
1Dyslipidemias (Dyslipidemia)
11/2019
1Obesity
11/2019
1Mood Disorders (Mood Disorder)
07/2015
1Vitamin D Deficiency
09/2014

Drug/Important Bio-Agent (IBA)

14Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 05/2010
11Sarcosine (Methylglycine)IBA
01/2021 - 01/2014
6Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2018 - 05/2010
5EndorphinsIBA
01/2021 - 01/2016
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2018 - 05/2010
4Glycine Plasma Membrane Transport ProteinsIBA
10/2018 - 01/2014
4Ribavirin (Virazole)FDA LinkGeneric
11/2008 - 06/2008
4Interferon-alpha (Interferon Alfa)IBA
11/2008 - 06/2008
3Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2022 - 08/2016
3Interleukin-6 (Interleukin 6)IBA
02/2022 - 01/2018
3DEAE-Dextran (Pulsar)IBA
01/2021 - 01/2015
3beta-Endorphin (Endorphin, beta)IBA
09/2020 - 01/2016
2CytokinesIBA
03/2022 - 10/2020
2AntioxidantsIBA
02/2022 - 01/2016
2Opioid Analgesics (Opioids)IBA
01/2021 - 09/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 10/2018
2Biological ProductsIBA
01/2019 - 01/2019
2Cycloserine (Seromycin)FDA Link
01/2015 - 01/2014
1Malondialdehyde (Propanedial)IBA
02/2022
1Fatty Acids (Saturated Fatty Acids)IBA
02/2022
1Biomarkers (Surrogate Marker)IBA
02/2022
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
02/2022
1Carrier Proteins (Binding Protein)IBA
02/2022
1zonulinIBA
02/2022
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
12/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1Neuropeptide YIBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Morphine (MS Contin)FDA LinkGeneric
01/2019
1Polytetrafluoroethylene (Teflon)FDA Link
01/2019
1ORALIT (ORS)IBA
01/2018
1Amino AcidsFDA Link
10/2015
1Protons (Proton)IBA
10/2015
1Choline (Choline Chloride)IBA
10/2015
1Aminobutyrates (Aminobutyric Acid)IBA
10/2015
1CreatineIBA
10/2015
1Glutamine (L-Glutamine)FDA Link
10/2015
1gamma-Aminobutyric Acid (GABA)IBA
10/2015
1Glutamic Acid (Glutamate)FDA Link
10/2015
1Inositol (Myoinositol)IBA
10/2015
1N-acetylaspartate (N-acetyl aspartate)IBA
10/2015
1Antidepressive Agents (Antidepressants)IBA
10/2015
1LipidsIBA
07/2015
1oxidized low density lipoproteinIBA
07/2015
1C-Reactive ProteinIBA
07/2015
1CholesterolIBA
07/2015
1Glucose (Dextrose)FDA LinkGeneric
07/2015
1LDL CholesterolIBA
07/2015
1Triglycerides (Triacylglycerol)IBA
07/2015
1Pharmaceutical PreparationsIBA
01/2015
1(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA
01/2015
1Olanzapine (Zyprexa)FDA Link
01/2015
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2015
1VitaminsIBA
09/2014
1Vitamin DFDA LinkGeneric
09/2014
1hydroxide ionIBA
09/2014
1Excitatory Amino Acid AgentsIBA
01/2014
1Memantine (Namenda)FDA Link
12/2013

Therapy/Procedure

4Therapeutics
10/2015 - 11/2008
2Aftercare (After-Treatment)
01/2016 - 09/2008
1Drug Therapy (Chemotherapy)
10/2015